SCHEMBL2365871

SCHEMBL2365871

COC(=O)c1cc(Br)c(=O)[nH]c1CCl

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.41
GLA P06280 1/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 3/20 0.40
ALDH1A1 P00352 4/20 0.39
PDE3B Q13370 1/20 0.38
PDE3A Q14432 1/20 0.38
RXFP1 Q9HBX9 1/20 0.37
SOS1 Q07889 1/20 0.37
NR4A2 P43354 1/20 0.35
XDH P47989 1/20 0.35
CHEK1 O14757 2/20 0.35
CYP1A2 P05177 1/20 0.35
SERPINH1 P50454 1/20 0.34
ABL1 P00519 1/20 0.33
HPGD P15428 1/20 0.33
MAPK10 P53779 2/20 0.33
USP2 O75604 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2365705 0.73 CHEK1 (0.48) KDM4EGLAGAAMAPTALDH1A1
SCHEMBL23051540 0.70 SOS1 (0.50) KDM4EGLAGAAMAPTALDH1A1
SCHEMBL197110 0.70 SOS1 (0.50) KDM4EGLAGAAMAPTALDH1A1
SCHEMBL22302580 0.68 ALDH1A1 (0.44) KDM4EGLAGAAMAPTALDH1A1
SCHEMBL7908962 0.68 GRIN2D (0.54) KDM4EGLAGAAMAPTALDH1A1
SCHEMBL4906582 0.68 SOS1 (0.44) KDM4EGLAGAAMAPTALDH1A1
SCHEMBL31385513 0.67 ALDH1A1 (0.49) KDM4EGAAMAPTALDH1A1SOS1
SCHEMBL4668796 0.67 SOS1 (0.49) KDM4EGLAGAAMAPTALDH1A1
SCHEMBL4907153 0.67 KDM4E (0.44) KDM4EGLAGAAMAPTALDH1A1
SCHEMBL9139468 0.66 ABL1 (0.41) KDM4EGAAMAPTSOS1NR4A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2364973-B1 HETEROCYCLIC INHIBITORS OF MEK AND METHODS OF USE THEREOF ARRAY BIOPHARMA INC (US) 2014-07-09 EP disclosed
EP-2364973-A1 Heterocyclic inhibitors of MEK and Methods of use thereof Array Biopharma, Inc. (US) 2011-09-14 EP disclosed
EP-2134340-A1 COMBINATION THERAPY COMPRISING AZD2171 AND AZD6244 OR MEK-INHIBITOR II AstraZeneca AB (SE) 2009-12-23 EP disclosed
WO-2008125820-A1 COMBINATION THERAPY COMPRISING AZD2171 AND AZD6244 OR MEK-INHIBITOR II ASTRAZENECA AB (SE) 2008-10-23 WO disclosed
WO-2008120004-A1 COMBINATION OF A MEK- INHIBITOR AND A B-RAF INHIBITOR FOR THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2008-10-09 WO disclosed